How does presurgical chemotherapy influence the efficiency of treatment for esophageal cancer recurrence after curative esophagectomy?

The effectiveness of treatments for recurrent esophageal squamous cell carcinoma (ESCC), particularly chemotherapy and chemoradiotherapy (CRT), remains unclear in patients who have previously been administered the same drugs during neoadjuvant chemotherapy.

[1]  Ken Kato,et al.  A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy , 2014, Cancer Chemotherapy and Pharmacology.

[2]  S. Kawasaki,et al.  Pattern of Postoperative Recurrence and Hepatic and/or Pulmonary Resection for Liver and/or Lung Metastases From Esophageal Carcinoma , 2013, World Journal of Surgery.

[3]  K. Jingu,et al.  Long-term bresults of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study , 2012, BMC Cancer.

[4]  K. Muro,et al.  Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). , 2011, International journal of radiation oncology, biology, physics.

[5]  K. Jingu,et al.  Long-term results of radiochemotherapy for solitary lymph node metastasis after curative resection of esophageal cancer. , 2011, International journal of radiation oncology, biology, physics.

[6]  Y. Doki,et al.  Survival Factors in Patients with Recurrence After Curative Resection of Esophageal Squamous Cell Carcinomas , 2011, Annals of Surgical Oncology.

[7]  S. Motoyama,et al.  Therapeutic strategy for the treatment of postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy of radiotherapy. , 2011, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[8]  Yu-Chung Wu,et al.  Prognostic Factors for Post-recurrence Survival in Esophageal Squamous Cell Carcinoma Patients with Recurrence after Resection , 2011, Journal of Gastrointestinal Surgery.

[9]  L. Stitt,et al.  What are the factors that predict outcome at relapse after previous esophagectomy and adjuvant therapy in high-risk esophageal cancer? , 2010, Current oncology.

[10]  E. Oki,et al.  Follow-up and recurrence after a curative esophagectomy for patients with esophageal cancer: the first indicators for recurrence and their prognostic values , 2010, Esophagus.

[11]  S. Kato,et al.  Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. , 2009, International journal of radiation oncology, biology, physics.

[12]  H. Shimada,et al.  Surgical Outcomes in Esophageal Cancer Patients with Tumor Recurrence After Curative Esophagectomy , 2008, Journal of Gastrointestinal Surgery.

[13]  H. Okumura,et al.  Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[14]  S. Yoshida,et al.  Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. , 2003, International journal of radiation oncology, biology, physics.

[15]  M. Shinoda,et al.  Title A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus ( JCOG 9907 ) , 2017 .

[16]  E. Oki,et al.  Clinical Significance of Surgical Resection for the Recurrence of Esophageal Cancer After Radical Esophagectomy , 2014, Annals of Surgical Oncology.

[17]  M. Shinoda,et al.  A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907) , 2011, Annals of Surgical Oncology.

[18]  George D Wilson,et al.  Biologic basis for combining drugs with radiation. , 2006, Seminars in radiation oncology.